Middle Africa vs Norway: Proportion of the target population who received a 3rd dose of
Middle Africa
56.0%
in 2024
Norway
95.0%
in 2024
Middle Africa rank
28th
Norway rank
28th
Proportion of the target population who received a 3rd dose of over time
- Middle Africa
- Norway
How they compare
Norway currently reports 95.0% against 56.0% in Middle Africa, a difference of 39.0%.
That makes Norway's figure about 1.7 times Middle Africa's.
Across all 14 years both countries report, Norway has been ahead every year.
Middle Africa ranks 28th and Norway ranks 28th of 37 groups.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Middle Africa | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 44.8% | 93.2% | 48.4% | Norway |
| 2020s | 55.2% | 95.4% | 40.2% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Middle Africa or Norway?
- Norway, at 95.0% against 56.0% in Middle Africa as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Middle Africa and Norway?
- 39.0%, with Norway ahead.
- How many years of comparable data are there for Middle Africa and Norway?
- 14 years are reported by both, from 2011 to 2024.
- How do Middle Africa and Norway rank globally for proportion of the target population who received a 3rd dose of?
- Middle Africa ranks 28th and Norway ranks 28th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.